Barbara Murphy
Faculty Member

  1. Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study. Bond SM, Hawkins DK, Murphy BA (2014) Cancer Nurs 37(3): 227-35
    › Primary publication · 23619332 (PubMed) · PMC4304699 (PubMed Central)
  2. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Kolnick L, Deng J, Epstein JB, Migliorati CA, Rezk J, Dietrich MS, Murphy BA (2014) Oral Oncol 50(2): 135-40
    › Primary publication · 24239279 (PubMed)
  3. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA (2013) Cancer 119(24): 4268-76
    › Primary publication · 24114811 (PubMed)
  4. Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Deng J, Murphy BA, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Gilbert J, Ridner SH (2013) Head Neck 35(7): 1026-35
    › Primary publication · 22791550 (PubMed) · PMC4017911 (PubMed Central)
  5. Body image in patients with head and neck cancer: a review of the literature. Rhoten BA, Murphy B, Ridner SH (2013) Oral Oncol 49(8): 753-60
    › Primary publication · 23683468 (PubMed)
  6. Assessment of external lymphedema in patients with head and neck cancer: a comparison of four scales. Deng J, Ridner SH, Dietrich MS, Wells N, Murphy BA (2013) Oncol Nurs Forum 40(5): 501-6
    › Primary publication · 23989023 (PubMed)
  7. Cancer pain management in ambulatory care: can we link assessment and action to outcomes? Wells N, McDowell MR, Hendricks P, Dietrich MS, Murphy B (2011) Support Care Cancer 19(11): 1865-71
    › Primary publication · 21052733 (PubMed) · PMC3103757 (PubMed Central)
  8. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Murphy BA, Dietrich MS, Wells N, Dwyer K, Ridner SH, Silver HJ, Gilbert J, Chung CH, Cmelak A, Burkey B, Yarbrough WG, Sinard R, Netterville J (2010) Head Neck 32(1): 26-37
    › Primary publication · 19626644 (PubMed)
  9. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. Hatakeyama H, Cheng H, Wirth P, Counsell A, Marcrom SR, Wood CB, Pohlmann PR, Gilbert J, Murphy B, Yarbrough WG, Wheeler DL, Harari PM, Guo Y, Shyr Y, Slebos RJ, Chung CH (2010) PLoS One 5(9): e12702
    › Primary publication · 20856931 (PubMed) · PMC2938338 (PubMed Central)
  10. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ (2010) Int J Radiat Oncol Biol Phys 77(2): 468-76
    › Primary publication · 19577867 (PubMed)